{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:20:24Z","timestamp":1790965224943,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF19H090020"],"award-info":[{"award-number":["LGF19H090020"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81901679"],"award-info":[{"award-number":["81901679"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an autoimmune demyelinating disorder of the central nervous system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Extracted proteins from 34 cerebrospinal fluid (CSF) samples [patients with MOGAD (MOG group, <jats:italic>n<\/jats:italic>\u2009=\u200912); healthy controls (HC group, <jats:italic>n<\/jats:italic>\u2009=\u200912); patients with MOG seronegative and metagenomics next-generation sequencing-negative inflammatory neurological diseases (IND group, <jats:italic>n<\/jats:italic>\u2009=\u200910)] were processed and subjected to label-free quantitative proteomics. Supervised partial least squares-discriminant analysis (PLS-DA) and orthogonal PLS-DA (O-PLS-DA) models were also performed based on proteomics data. Functional analysis of differentially expressed proteins (DEPs) was performed using Gene Ontology, InterPro, and Kyoto Encyclopedia Genes and Genomes. An enzyme-linked immunosorbent assay was used to determine the complement levels in serum from patients with MOGAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four hundred and twenty-nine DEPs (149 upregulated and 280 downregulated proteins) were identified in the MOG group compared to the HC group according to the <jats:italic>P<\/jats:italic> value and fold change (FC). Using the O-PLS-DA model, 872 differentially abundant proteins were identified with variable importance projection (VIP) scores\u2009&gt;\u20091. Five proteins (gamma-glutamyl hydrolase, cathepsin F, interalpha-trypsin inhibitor heavy chain 5, latent transforming growth factor beta-binding protein 4 and leukocyte-associated immunoglobulin-like receptor 1) overlapping between the top 30 DEPs with top-ranked <jats:italic>P<\/jats:italic> value and FC and top 30 proteins in PLS-DA VIP lists were acquired. Functional analysis revealed that the dysregulated proteins in the MOG group were primarily involved in complement and coagulation cascades, cell adhesion, axon guidance, and glycosphingolipid biosynthesis compared to the HC group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The proteomic alterations in CSF samples from children with MOGAD identified in the current study might provide opportunities for developing novel biomarker candidates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12519-022-00661-y","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T15:03:16Z","timestamp":1670857396000},"page":"259-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proteomic profiling of cerebrospinal fluid in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease"],"prefix":"10.1007","volume":"20","author":[{"given":"Yi-Long","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xia","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"661_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","volume":"72","author":"TG Johns","year":"1999","unstructured":"Johns TG, Bernard CC. The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem. 1999;72:1\u20139.","journal-title":"J Neurochem"},{"key":"661_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1471-4159.1995.65010309.x","volume":"65","author":"AA Hilton","year":"1995","unstructured":"Hilton AA, Slavin AJ, Hilton DJ, Bernard CC. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J Neurochem. 1995;65:309\u201318.","journal-title":"J Neurochem"},{"key":"661_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013;9:455\u201361.","journal-title":"Nat Rev Neurol"},{"key":"661_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Pr\u00f6bstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20:762\u201372.","journal-title":"Lancet Neurol"},{"key":"661_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15:89\u2013102.","journal-title":"Nat Rev Neurol"},{"key":"661_CR6","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","volume":"143","author":"Y Takai","year":"2020","unstructured":"Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143:1431\u201346.","journal-title":"Brain"},{"key":"661_CR7","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","volume":"89","author":"EM Hennes","year":"2017","unstructured":"Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 2017;89:900\u20138.","journal-title":"Neurology"},{"key":"661_CR8","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140:3128\u201338.","journal-title":"Brain"},{"key":"661_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ana.25909","volume":"89","author":"A Cobo-Calvo","year":"2021","unstructured":"Cobo-Calvo A, Ruiz A, Rollot F, Arrambide G, Deschamps R, Maillart E, et al. Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol. 2021;89:30\u201341.","journal-title":"Ann Neurol"},{"key":"661_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","volume":"77","author":"P Waters","year":"2020","unstructured":"Waters P, Fadda G, Woodhall M, O\u2019Mahony J, Brown RA, Castro DA, et al. Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. 2020;77:82\u201393.","journal-title":"JAMA Neurol"},{"key":"661_CR11","first-page":"1388","volume":"89","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Nervenarzt. 2018;89:1388-99 (in German).","journal-title":"J Neuroinflamm"},{"key":"661_CR12","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC, Reindl M, Lang B, Sato DK, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015;2:e89.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"661_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000674","author":"M Reindl","year":"2020","unstructured":"Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, et al. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm. 2020;7:e674.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"661_CR14","doi-asserted-by":"publisher","first-page":"W573","DOI":"10.1093\/nar\/gkab329","volume":"49","author":"E Theodorakis","year":"2021","unstructured":"Theodorakis E, Antonakis A, Baltsavia I, Pavlopoulos GA, Samiotaki M, Amoutzias GD, et al. ProteoSign v2: a faster and evolved user-friendly online tool for statistical analyses of differential proteomics. Nucleic Acids Res. 2021;49:W573\u20137.","journal-title":"Nucleic Acids Res"},{"key":"661_CR15","doi-asserted-by":"publisher","first-page":"733225","DOI":"10.3389\/fimmu.2021.733225","volume":"12","author":"R Dong","year":"2021","unstructured":"Dong R, Ye N, Zhao S, Wang G, Zhang Y, Wang T, et al. Studies on novel diagnostic and predictive biomarkers of intrahepatic cholestasis of pregnancy through metabolomics and proteomics. Front Immunol. 2021;12:733225.","journal-title":"Front Immunol"},{"key":"661_CR16","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/eurheartj\/ehv236","volume":"36","author":"IE Hoefer","year":"2015","unstructured":"Hoefer IE, Steffens S, Ala-Korpela M, B\u00e4ck M, Badimon L, Bochaton-Piallat M, et al. Novel methodologies for biomarker discovery in atherosclerosis. Eur Heart J. 2015;36:2635\u201342.","journal-title":"Eur Heart J"},{"key":"661_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, Chen P, Yu K, Dey K, et al. Deep multilayer brain proteomics identifies molecular networks in alzheimer\u2019s disease progression. Neuron. 2020;106:700.","journal-title":"Neuron"},{"key":"661_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41581-020-00348-5","volume":"17","author":"MM Rinschen","year":"2021","unstructured":"Rinschen MM, Saez-Rodriguez J. The tissue proteome in the multi-omic landscape of kidney disease. Nat Rev Nephrol. 2021;17:205\u201319.","journal-title":"Nat Rev Nephrol"},{"key":"661_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41582-020-0350-6","volume":"16","author":"J Montaner","year":"2020","unstructured":"Montaner J, Ramiro L, Simats A, Tiedt S, Makris K, Jickling G, et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol. 2020;16:247\u201364.","journal-title":"Nat Rev Neurol"},{"key":"661_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/metabo10090374","volume":"10","author":"ME Thoman","year":"2020","unstructured":"Thoman ME, McKarns SC. Metabolomic profiling in neuromyelitis optica spectrum disorder biomarker discovery. Metabolites. 2020;10:374.","journal-title":"Metabolites"},{"key":"661_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jnc.15295","volume":"157","author":"ME Williams","year":"2021","unstructured":"Williams ME, Naud\u00e9 PJW, van der Westhuizen FH. Proteomics and metabolomics of HIV-associated neurocognitive disorders: a systematic review. J Neurochem. 2021;157:429\u201349.","journal-title":"J Neurochem"},{"key":"661_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab084","author":"F Probert","year":"2021","unstructured":"Probert F, Yeo T, Zhou Y, Sealey M, Arora S, Palace J, et al. Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis. Brain Commun. 2021;3:fcab084.","journal-title":"Brain Commun"},{"key":"661_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41531-021-00249-9","volume":"7","author":"TM Marques","year":"2021","unstructured":"Marques TM, van Rumund A, Kersten I, Bruinsma IB, Wessels HUCT, Gloerich J, et al. Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. NPJ Parkinsons Dis. 2021;7:107.","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"661_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-020-00388-2","volume":"15","author":"I van Steenoven","year":"2020","unstructured":"van Steenoven I, Koel-Simmelink MJA, Vergouw LJM, Tijms BM, Piersma SR, Pham TV, et al. Identification of novel cerebrospinal fluid biomarker candidates for dementia with lewy bodies: a proteomic approach. Mol Neurodegener. 2020;15:36.","journal-title":"Mol Neurodegener"},{"key":"661_CR25","doi-asserted-by":"publisher","first-page":"e9356","DOI":"10.15252\/msb.20199356","volume":"16","author":"JM Bader","year":"2020","unstructured":"Bader JM, Geyer PE, M\u00fcller JB, Strauss MT, Koch M, Leypoldt F, et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease. Mol Syst Biol. 2020;16:e9356.","journal-title":"Mol Syst Biol"},{"key":"661_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-021-00814-7","volume":"13","author":"C Clark","year":"2021","unstructured":"Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:71.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"661_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell. 2016;166:755\u201365.","journal-title":"Cell"},{"key":"661_CR28","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics. 2014;30:1236\u201340.","journal-title":"Bioinformatics"},{"key":"661_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W da Huang","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"661_CR30","doi-asserted-by":"publisher","first-page":"O111.016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012;11:O111.016717.","journal-title":"Mol Cell Proteomics"},{"key":"661_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000275945","volume":"56","author":"JH Lee","year":"2010","unstructured":"Lee JH, Lee YA, Oh KH, Chang N. Effects of dietary folic acid on the expression of myelin basic protein in the brain and spinal cord of pregnant and lactating rats. Ann Nutr Metab. 2010;56:83\u201390.","journal-title":"Ann Nutr Metab"},{"key":"661_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0022-2836(02)00780-5","volume":"322","author":"JR Somoza","year":"2002","unstructured":"Somoza JR, Palmer JT, Ho JD. The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J Mol Biol. 2002;322:559\u201368.","journal-title":"J Mol Biol"},{"key":"661_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-017-0984-5","volume":"14","author":"P Peschl","year":"2017","unstructured":"Peschl P, Schanda K, Zeka B, Given K, B\u00f6hm D, Ruprecht K, et al. Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination. J Neuroinflamm. 2017;14:208.","journal-title":"J Neuroinflamm"},{"key":"661_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.25291","volume":"84","author":"M Spadaro","year":"2018","unstructured":"Spadaro M, Winklmeier S, Beltr\u00e1n E, Macrini C, H\u00f6ftberger R, Schuh E, et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann Neurol. 2018;84:315\u201328.","journal-title":"Ann Neurol"},{"key":"661_CR35","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1021\/acs.jproteome.0c00307","volume":"19","author":"Z Sun","year":"2020","unstructured":"Sun Z, Li W, Xu J, Ren K, Gao F, Jiang Z, et al. Proteomic analysis of cerebrospinal fluid in children with acute enterovirus-associated meningoencephalitis identifies dysregulated host processes and potential biomarkers. J Proteome Res. 2020;19:3487\u201398.","journal-title":"J Proteome Res"},{"key":"661_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","volume":"85","author":"R Steinfeld","year":"2009","unstructured":"Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet. 2009;85:354\u201363.","journal-title":"Am J Hum Genet"},{"key":"661_CR37","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3324\/haematol.2017.171074","volume":"102","author":"CJ Henry","year":"2017","unstructured":"Henry CJ, Nemkov T, Casas-Selves M, Bilousova G, Zaberezhnyy V, Higa KC, et al. Folate dietary insufficiency and folic acid supplementation similarly impair metabolism and compromise hematopoiesis. Haematologica. 2017;102:1985\u201394.","journal-title":"Haematologica"},{"key":"661_CR38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1084\/jem.191.7.1177","volume":"191","author":"GP Shi","year":"2000","unstructured":"Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, et al. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J Exp Med. 2000;191:1177\u201386.","journal-title":"J Exp Med"},{"key":"661_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1212\/WNL.44.4.745","volume":"44","author":"CT Bever Jr","year":"1994","unstructured":"Bever CT Jr, Panitch HS, Johnson KP. Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients. Neurology. 1994;44:745\u20138.","journal-title":"Neurology"},{"key":"661_CR40","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1212\/NXI.0000000000000335","volume":"4","author":"P K\u00f6rtv\u00e9lyessy","year":"2017","unstructured":"K\u00f6rtv\u00e9lyessy P, Breu M, Pawlitzki M, Metz I, Heinze H, Matzke M, et al. ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports. Neurol Neuroimmunol Neuroinflamm. 2017;4:e335.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"661_CR41","doi-asserted-by":"publisher","first-page":"175628641876208","DOI":"10.1177\/1756286418762083","volume":"11","author":"MS Weber","year":"2018","unstructured":"Weber MS, Derfuss T, Metz I, Br\u00fcck W. Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord. 2018;11:1756286418762083.","journal-title":"Ther Adv Neurol Disord"},{"key":"661_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molimm.2018.06.007","volume":"102","author":"AL Kj\u00e6ldgaard","year":"2018","unstructured":"Kj\u00e6ldgaard AL, Pilely K, Olsen KS, Pedersen SW, Lauritsen A\u00d8, M\u00f8ller K, et al. Amyotrophic lateral sclerosis: the complement and inflammatory hypothesis. Mol Immunol. 2018;102:14\u201325.","journal-title":"Mol Immunol"},{"key":"661_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol Commun. 2019;7:169.","journal-title":"Acta Neuropathol Commun"},{"key":"661_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/13524585211010082","volume":"28","author":"M Comabella","year":"2022","unstructured":"Comabella M, Clarke MA, Schaedelin S, Tintor\u00e9 M, Pareto D, Fissolo N, et al. CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event. Mult Scler. 2022;28:71\u201381.","journal-title":"Mult Scler"},{"key":"661_CR45","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"C Stadelmann","year":"2019","unstructured":"Stadelmann C, Timmler S, Barrantes-Freer A, Simons M. Myelin in the central nervous system: structure, function, and pathology. Physiol Rev. 2019;99:1381\u2013431.","journal-title":"Physiol Rev"},{"key":"661_CR46","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/ijms9081504","volume":"9","author":"S Tannukit","year":"2008","unstructured":"Tannukit S, Wen X, Wang H, Paine ML. TFIP11, CCNL1 and EWSR1 protein-protein Interactions, and their nuclear localization. Int J Mol Sci. 2008;9:1504\u201314.","journal-title":"Int J Mol Sci"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-022-00661-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00661-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T16:13:25Z","timestamp":1711037605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-022-00661-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1007\/s12519-022-00661-y","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval was obtained from the Ethics Committee of Children\u2019s Hospital, Zhejiang University School of Medicine (2021-IRB-161).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. None of the authors has any conflict of interest to disclose. Author Zheng-Yan Zhao is the Chief Editor of <i>World Journal of Pediatrics<\/i>. The paper was handled by the other Editor and has undergone a rigorous peer-review process. Author Zheng-Yan Zhao was not involved in the journal's review or decision making of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}